Influence of different growth factors on chondrogenic differentiation of adipose-derived stem cells in polyurethane-fibrin composites

International Journal of Artificial Organs

Volumn 35, Issue 12, 2012, Pages 1047-1060

  Froelich, Katrin ^a   Setiawan, Lydia E ^a   Technau, Antje ^a   Tirado, Mario Ramos ^a   Hackenberg, Stephan ^a   Hagen, Rudolf ^a   Staudenmaier, Rainer ^b   Kleinsasser, Norbert H ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adipose tissue derived stromal cells; Cartilage tissue engineering; Chondrogenic differentiation; Polyurethane; Vocal cord palsy

Indexed keywords

CARTILAGE; CELL ENGINEERING; COLLAGEN; CYTOLOGY; DEFECTS; GENE EXPRESSION; GLYCOPROTEINS; POLYURETHANES; SCAFFOLDS (BIOLOGY); STEM CELLS;

ADIPOSE DERIVED STEM CELLS; ADIPOSE TISSUE; ADIPOSE TISSUE-DERIVED STROMAL CELL; CARTILAGE TISSUE ENGINEERING; CHONDROGENIC DIFFERENTIATION; COLLAGEN II; POLYURETHANE SCAFFOLDS; STROMAL CELLS; VOCAL CORD PALSY; VOCAL CORDS;

POLYMERASE CHAIN REACTION;

ACID GLYCOSAMINOGLYCAN; AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 2; FIBRIN; GROWTH FACTOR; MOLECULAR SCAFFOLD; POLYURETHAN; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ADIPOCYTE; ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; BONE CELL; BONE DEVELOPMENT; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MALE; NORMAL HUMAN; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84872862975     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000132     Document Type: Article

References (67)

1. Brünings W. Über eine neue Behandlungsmethode der Rekurrenslähmung. Verh Dtsch Laryngol. 1911;18:93-151.
2. Payr E. Plastik am Schildknorpel zur Behebung der Folgen einseitiger Stimmlippenlähmung. Dtsch Med Wochenschr. 1914;43:1265-1270.
3. Isshiki N, Morita H, Okamura H, Hiramoto M. Thyroplasty as a new phonosurgical technique. Acta Otolaryngol. 1974; 78(5-6):451-457.
4. Friedrich G. Externe Stimmlippenmedialisation: Operative Erfahrungen und Modifikationen (in German) [External vocal fold medialization: surgical experiences and modifications]. Laryngorhinootologie. 1998;77(1):7-17.
5. McCulloch TM, Andrews BT, Hoffman HT, Graham SM, Karnell MP, Minnick C. Long-term follow-up of fat injection laryngoplasty for unilateral vocal cord paralysis. Laryngoscope. 2002;112(7 Pt 1):1235-1238.
6. Laccourreye O, Hans S. Endolaryngeal extrusion of expanded polytetrafluoroethylene implant after medialization thyroplasty. Ann Otol Rhinol Laryngol. 2003;112(11): 962-964.
7. Laccourreye O, Papon JF, Kania R, Crevier-Buchman L, Brasnu D, Hans S. Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: longterm results from the patient's perspective. Laryngoscope. 2003;113(3):541-545.
8. Sittel C, Thumfart WF, Pototschnig C, Wittekindt C, Eckel HE. Textured polydimethylsiloxane elastomers in the human larynx: safety and efficiency of use. J Biomed Mater Res. 2000;53(6):646-650.
9. Zapanta PE, Bielamowicz SA. Laryngeal abscess after injection laryngoplasty with micronized AlloDerm. Laryngoscope. 2004;114(9):1522-1524.
10. Halum SL, Postma GN, Koufman JA. Endoscopic management of extruding medialization laryngoplasty implants. Laryngoscope. 2005;115(6):1051-1054.
11. Baijens L, Speyer R, Linssen M, Ceulen R, Manni JJ. Rejection of injectable silicone "Bioplastique" used for vocal fold augmentation. Eur Arch Otorhinolaryngol. 2007;264(5): 565-568.
12. Remacle M, Lawson G. Results with collagen injection into the vocal folds for medialization. Curr Opin Otolaryngol Head Neck Surg. 2007;15(3):148-152.
13. Pagedar NA, Listinsky CM, Tucker HM. An unusual presentation of Teflon granuloma: case report and discussion. Ear Nose Throat J. 2009;88(1):746-747.
14. Chhetri DK, Head C, Revazova E, Hart S, Bhuta S, Berke GS. Lamina propria replacement therapy with cultured autologous fibroblasts for vocal fold scars. Otolaryngol Head Neck Surg. 2004;131(6):864-870.
15. Kanemaru S, Nakamura T, Yamashita M, et al. Destiny of autologous bone marrow-derived stromal cells implanted in the vocal fold. Ann Otol Rhinol Laryngol. 2005;114(12): 907-912.
16. Lee BJ, Wang SG, Lee JC, et al. The prevention of vocal fold scarring using autologous adipose tissue-derived stromal cells. Cells Tissues Organs. 2006;184(3-4):198-204.
17. Halum SL, Naidu M, Delo DM, Atala A, Hingtgen CM. Injection of autologous muscle stem cells (myoblasts) for the treatment of vocal fold paralysis: a pilot study. Laryngoscope. 2007;117(5):917-922.
18. Lo Cicero V, Montelatici E, Cantarella G, et al. Do mesenchymal stem cells play a role in vocal fold fat graft survival? Cell Prolif. 2008;41(3):460-473.
19. Kumai Y, Kobler JB, Park H, Galindo M, Herrera VLM, Zeitels SM. Modulation of vocal fold scar fibroblasts by adiposederived stem/stromal cells. Laryngoscope. 2010;120(2): 330-337.
20. Kutty JK, Webb K. Tissue engineering therapies for the vocal fold lamina propria. Tissue Eng Part B Rev. 2009;15(3): 249-262.
21. Johnson BQ, Fox R, Chen X, Thibeault S. Tissue regeneration of the vocal fold using bone marrow mesenchymal stem cells and synthetic extracellular matrix injections in rats. Laryngoscope. 2010;120(3):537-545.
22. Long JL, Zuk P, Berke GS, Chhetri DK. Epithelial differentiation of adipose-derived stem cells for laryngeal tissue engineering. Laryngoscope. 2010;120(1):125-131.
23. Long JL, Neubauer J, Zhang Z, Zuk P, Berke GS, Chhetri DK. Functional testing of a tissue-engineered vocal fold cover replacement. Otolaryngol Head Neck Surg. 2010;142(3): 438-440.
24. Park H, Karajanagi S, Wolak K, et al. Three-dimensional hydrogel model using adipose-derived stem cells for vocal fold augmentation. Tissue Eng Part A. 2010;16(2):535-543.
25. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100(9):1249-1260.
26. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005;54(3):132-141.
27. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adiposederived stem cells: isolation, expansion and differentiation. Methods. 2008;45(2):115-120.
28. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.
29. De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs. 2003;174(3):101-109.
30. Guilak F, Awad HA, Fermor B, Leddy HA, Gimble JM. Adipose-derived adult stem cells for cartilage tissue engineering. Biorheology. 2004;41(3-4):389-399.
31. Chetty A, Steynberg T, Moolman S, Nilen R, Joubert A, Richter W. Hydroxyapatite-coated polyurethane for auricular cartilage replacement: an in vitro study. J Biomed Mater Res A. 2008;84(2):475-482.
32. Grad S, Kupcsik L, Gorna K, Gogolewski S, Alini M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Biomaterials. 2003;24(28):5163-5171.
33. Lee CR, Grad S, Gorna K, Gogolewski S, Goessl A, Alini M. Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng. 2005; 11(9-10):1562-1573.
34. Eyrich D, Brandl F, Appel B, et al. Long-term stable fibrin gels for cartilage engineering. Biomaterials. 2007;28(1): 55-65.
35. Eyrich D, Wiese H, Maier G, et al. In vitro and in vivo cartilage engineering using a combination of chondrocyteseeded long-term stable fibrin gels and polycaprolactonebased polyurethane scaffolds. Tissue Eng. 2007;13(9): 2207-2218.
36. Dunn CJ, Goa KL. Fibrin sealant: a review of its use in surgery and endoscopy. Drugs. 1999;58(5):863-886.
37. Spector M. Novel cell-scaffold interactions encountered in tissue engineering: contractile behavior of musculoskeletal connective tissue cells. Tissue Eng. 2002;8(3):351-357.
38. Li Z, Kupcsik L, Yao SJ, Alini M, Stoddart MJ. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Eng Part A. 2009; 15(7):1729-1737.
39. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147.
40. Lev R, Spicer SS. Specific staining of sulphate groups with alcian blue at low pH. J Histochem Cytochem. 1964;12:309.
41. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402-408.
42. Lotz AS, Havla JB, Richter E, et al. Cytotoxic and genotoxic effects of matrices for cartilage tissue engineering. Toxicol Lett. 2009;190(2):128-133.
43. Havla JB, Lotz AS, Richter E, et al. Cartilage tissue engineering for auricular reconstruction: in vitro evaluation of potential genotoxic and cytotoxic effects of scaffold materials. Toxicol In Vitro. 2010;24(3):849-853.
44. Staudenmaier R, Hoang TN, Kleinsasser N, et al. Flap prefabrication and prelamination with tissue-engineered cartilage. J Reconstr Microsurg. 2004;20(7):555-564.
45. Hoang NT, Hoehnke C, Hien PT, Mandlik V, Feucht A, Staudenmaier R. Neovascularization and free microsurgical transfer of in vitro cartilage-engineered constructs. Microsurgery. 2009;29(1):52-61.
46. Sidelmann JJ, Gram J, Jespersen J, Kluft C. Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost. 2000;26(6):605-618.
47. Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247-299.
48. Jakobsen RB, Shahdadfar A, Reinholt FP, Brinchmann JE. Chondrogenesis in a hyaluronic acid scaffold: comparison between chondrocytes and MSC from bone marrow and adipose tissue. Knee Surg Sports Traumatol Arthrosc. 2010;18(10):1407-1416.
49. Im GI, Shin YW, Lee KB. Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthr Cartil. 2005;13(10):845-853.
50. Hennig T, Lorenz H, Thiel A, et al. Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFbeta receptor and BMP profile and is overcome by BMP-6. J Cell Physiol. 2007;211(3):682-691.
51. Afizah H, Yang Z, Hui JH, Ouyang HW, Lee EH. A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (AD-SCs) taken from the same donors. Tissue Eng. 2007;13(4): 659-666.
52. Kim HJ, Im GI. Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. J Orthop Res. 2009;27(5): 612-619.
53. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z. Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct. 2008;26(6):664-675.
54. Auquier P, Macquart-Moulin G, Moatti JP, et al. Comparison of anxiety, pain and discomfort in two procedures of hematopoietic stem cell collection: leukacytapheresis and bone marrow harvest. Bone Marrow Transplant. 1995;16(4): 541-547.
55. Nishimori M, Yamada Y, Hoshi K, et al. Health-related quality of life of unrelated bone marrow donors in Japan. Blood. 2002;99(6):1995-2001.
56. Kim HJ, Im GI. Combination of transforming growth factorbeta2 and bone morphogenetic protein 7 enhances chondrogenesis from adipose tissue-derived mesenchymal stem cells. Tissue Eng Part A. 2009;15(7):1543-1551.
57. Puetzer JL, Petitte JN, Loboa EG. Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue. Tissue Eng Part B Rev. 2010;16(4):435-444.
58. Freyria AM, Mallein-Gerin F. Chondrocytes or adult stem cells for cartilage repair: The indisputable role of growth factors. Injury. 2012;43(3):259-65.
59. Ito T, Sawada R, Fujiwara Y, Tsuchiya T. FGF-2 increases osteogenic and chondrogenic differentiation potentials of human mesenchymal stem cells by inactivation of TGF-beta signaling. Cytotechnology. 2008;56(1):1-7.
60. Perrier E, Ronzière MC, Bareille R, Pinzano A, Mallein-Gerin F, Freyria AM. Analysis of collagen expression during chondrogenic induction of human bone marrow mesenchymal stem cells. Biotechnol Lett. 2011;33(10):2091-2101.
61. Hildner F, Peterbauer A, Wolbank S, et al. FGF-2 abolishes the chondrogenic effect of combined BMP-6 and TGF-beta in human adipose derived stem cells. J Biomed Mater Res A. 2010;94(3):978-987.
62. Estes BT, Wu AW, Guilak F. Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis Rheum. 2006;54(4):1222-1232.
63. Wei Y, Hu Y, Lv R, Li D. Regulation of adipose-derived adult stem cells differentiating into chondrocytes with the use of rhBMP-2. Cytotherapy. 2006;8(6):570-579.
64. Ronzière MC, Perrier E, Mallein-Gerin F, Freyria AM. Chondrogenic potential of bone marrow- and adipose tissuederivedadult human mesenchymal stem cells. Biomed Mater Eng. 2010;20(3):145-158.
65. Mehlhorn AT, Niemeyer P, Kaschte K, et al. Differential effects of BMP-2 and TGF-beta1 on chondrogenic differentiation of adipose derived stem cells. Cell Prolif. 2007;40(6): 809-823.
66. Shen B, Wei A, Tao H, Diwan AD, Ma DD. BMP-2 enhances TGF-beta3-mediated chondrogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in alginate bead culture. Tissue Eng Part A. 2009;15(6):1311-1320.
67. An C, Cheng Y, Yuan Q, Li J. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells. Ann Biomed Eng. 2010;38(4): 1647-1654.